
G-protein coupled receptors (GPCRs) are one of the largest gene families of signaling proteins. Residing in the plasma membrane with seven transmembrane domains, GPCRs respond to extracellular stimuli that include catecholamine neurotransmitters, neuropeptides, larger protein hormones, lipids, nucleotides and other biological molecules. When a GPCR binds its extracellular ligand, it interacts with a G-protein to transduce a signal across the membrane into the cellular interior. G-proteins are a heterotrimeric complex containing a Ga subunit with GTPase activity, as well as b and g subunits. Ga can exist in an active state and an inactive state. Ga in the off state has GDP bound and does not activate downstream signaling molecules. When a GPCR is activated by ligand, it stimulates Ga subunits to bind GTP instead of GDP and become active, dissociating from the receptor and from the b/g subunits to activate downstream signaling factors like the enzyme adenylyl cyclase that synthesizes cyclic-AMP (cAMP) from ATP. Ga turns itself back off again with its intrinsic GTPase activity, hydrolyzing GTP to GDP to become inactive again.Activated G proteins interact with downstream signaling factors to alter the production of second messenger signaling molecules like inositolphosphates, calcium and cAMP. GPCRs that activate the Gi class of Ga subunits inhibit cAMP production and GPCRs that activate the Gs class of Ga subunits activate cAMP production. cAMP in turn activates the cAMP-dependent protein kinase, protein kinase A (PKA). PKA is a tetramer composed of catalytic subunits and regulatory subunits that repress the catalytic units when they are bound together. The regulatory subunits bind cAMP when it is present and release the catalytic units, releasing their inhibition of the catalytic subunits as well. The catalytic subunits of PKA when they are released and active phosphorylate target substrate proteins on serine and threonine residues, altering the activity of the modified protein and creating a cellular response to the extracellular stimulus acting on the GPCR.The PKA activation pathway is an example of a signal transduction cascade, in which tying several signaling events together amplifies the original signal in the cell. For each GPCR molecule that is activated, many G-proteins can be activated, and each active G protein can synthesize many cAMP molecules, continuing the cascade to PKA and further downstream. One of the roles of PKA that was first studied was the regulation of glycogen metabolism. When epinephrine binds to its receptor in liver, it activates cAMP production and PKA activation. One substrate of PKA is phosphorylase kinase, which is activated phosphorylation and is part of the signaling cascade that mobilizes glycogen into glucose to provide energy that fuels the response to epinephrine. Another substrate of PKA is glycogen synthase, which is turned off by PKA phosphorylation. PKA also participates in many other signaling pathways, integrating the key signaling intermediary cAMP with a wide range of biological responses
Contributor: Glenn Croston, PhD.
REFERENCES:
IlluminaProteinPrep可检测9,500种独特的人类蛋白质靶标,为蛋白质生物学提供全新洞察,推动疾病治疗新发现早期试用客户充分认可了其大规模检测能力、高度一致性以及简便的“从样本到洞察”......
蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......
蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......
2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......
2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......
天然免疫应答是机体应对病原微生物入侵的第一道防线,在杀伤病原微生物、清除感染细胞和维持体内稳态等方面发挥关键作用。蛋白质翻译后修饰(proteinpost-translationalmodificat......
脂滴是一种具有中性脂质核心的膜性细胞器。与其他膜性细胞器的根本区别就是脂滴由单分子磷脂膜包被,而其他膜性细胞器由双分子磷脂膜与外界隔离。脂滴最早由列文虎克于1674年在牛奶里发现,是人类最早发现的膜性......
磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......
分析测试百科网讯随着生命科学产业的数字化转型和向精密医学的推进,集成以增强SCIEX高分辨率精确大众平台的快速数据处理能力继续推动数据需求。生命科学分析技术领域专业企业——SCIEX宣布与蛋白质特性质......
2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......